Literature DB >> 32056164

MicroRNA-498 inhibits the proliferation, migration and invasion of gastric cancer through targeting BMI-1 and suppressing AKT pathway.

Dong You1, Dawei Wang1, Peiji Liu1, Yuning Chu2, Xueying Zhang2, Xueli Ding3, Xiaoyu Li3, Tao Mao3, Xue Jing3, Zibin Tian3, Yinghua Pan4.   

Abstract

Recently, microRNA-498 (miR-498) plays important effect in human cancers. Nonetheless, the role of miR-498 is still unclear in gastric cancer (GC). Therefore, this study was designed to investigate the function of miR-498 in GC tissues and cell lines (SGC-7901, BGC-823, MGC-803). The expressions of miR-498 and BMI-1 were examined in GC tissues via the RT-qPCR assay. The function of miR-498 was investigated through MTT and transwell assays. The relationship between miR-498 and BMI-1 was testified by dual luciferase assay. The protein expression of EMT markers, AKT pathway markers and BMI-1 was measured through western blot. The expression of miR-498 was decreased in GC tissues which predicted poor prognosis of GC patients. Moreover, functional analyses show that the overexpression of miR-498 inhibited the progression of GC. Furthermore, BMI-1 was a direct target of miR-498 which was upregulated in GC. Especially, the upregulation of BMI-1 recovered the suppressive effect of miR-498 in GC. In addition, miR-498 inhibited the metastasis and proliferation of GC cells through blocking EMT and AKT pathway. MiR-498, by targeting BMI-1, presents a plethora of tumor suppressor activities in GC cells.

Entities:  

Keywords:  AKT pathway; BMI-1; Gastric cancer; MiR-498

Mesh:

Substances:

Year:  2020        PMID: 32056164     DOI: 10.1007/s13577-019-00313-w

Source DB:  PubMed          Journal:  Hum Cell        ISSN: 0914-7470            Impact factor:   4.374


  42 in total

1.  Gastric cancer incidence and mortality in Zhuanghe, China, between 2005 and 2010.

Authors:  Jing-Jing Jing; Hui-Yuan Liu; Jin-Kuan Hao; Li-Na Wang; Yun-Ping Wang; Li-Hua Sun; Yuan Yuan
Journal:  World J Gastroenterol       Date:  2012-03-21       Impact factor: 5.742

Review 2.  The diverse functions of microRNAs in animal development and disease.

Authors:  Wigard P Kloosterman; Ronald H A Plasterk
Journal:  Dev Cell       Date:  2006-10       Impact factor: 12.270

Review 3.  The treatment of advanced gastric cancer: current strategies and future perspectives.

Authors:  A Cervantes; S Roselló; D Roda; E Rodríguez-Braun
Journal:  Ann Oncol       Date:  2008-07       Impact factor: 32.976

4.  MiR-208a enhances cell proliferation and invasion of gastric cancer by targeting SFRP1 and negatively regulating MEG3.

Authors:  Hai-Bin Cui; Huai-E Ge; Yong-Sen Wang; Xi-Yong Bai
Journal:  Int J Biochem Cell Biol       Date:  2018-06-08       Impact factor: 5.085

5.  Gastric cancer.

Authors:  Tetsuji Fujita
Journal:  Lancet       Date:  2009-11-07       Impact factor: 79.321

6.  Downregulation of MiR-1297 predicts poor prognosis and enhances gastric cancer cell growth by targeting CREB1.

Authors:  Wencang Gao; Ying Cao; Piaoting Guo; Xiaoyan Bao; Hongye Zhu; Jian Zheng; Cheng Yao; Dong Chen; Shenquan Yu; Binhai Chen; Shaoling Zhou; Dexiang Pang; Weijian Chen
Journal:  Biomed Pharmacother       Date:  2018-06-02       Impact factor: 6.529

7.  Cancer statistics, 2015.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2015-01-05       Impact factor: 508.702

8.  Prognostic factors for survival of patients with advanced gastric cancer treated with cisplatin-based chemotherapy.

Authors:  Jong Gwang Kim; Baek-Yeol Ryoo; Yeon Hee Park; Bong-Seog Kim; Tae-You Kim; Young-Hyuck Im; Yoon-Koo Kang
Journal:  Cancer Chemother Pharmacol       Date:  2007-04-12       Impact factor: 3.333

Review 9.  Evolution of Gastric Cancer Treatment: From the Golden Age of Surgery to an Era of Precision Medicine.

Authors:  Yoon Young Choi; Sung Hoon Noh; Jae-Ho Cheong
Journal:  Yonsei Med J       Date:  2015-09       Impact factor: 2.759

Review 10.  Gastric cáncer: Overview.

Authors:  M Blanca Piazuelo; Pelayo Correa
Journal:  Colomb Med (Cali)       Date:  2013-09-30
View more
  5 in total

1.  LINC01255 combined with BMI1 to regulate human mesenchymal stromal senescence and acute myeloid leukemia cell proliferation through repressing transcription of MCP-1.

Authors:  Q Liu; H Zhang; J Dong; J Li; Y Duan; K Wang; Q Kong
Journal:  Clin Transl Oncol       Date:  2021-01-06       Impact factor: 3.405

2.  MicroRNA-489-3p plays a significant role in congenital hypothyroidism through regulating neuronal cell apoptosis via targeting translationally controlled tumor protein 1.

Authors:  Qin Liu; Yuehong Li; Yong Zhou
Journal:  Exp Ther Med       Date:  2021-01-20       Impact factor: 2.447

3.  Circ_0000658 knockdown inhibits epithelial-mesenchymal transition in bladder cancer via miR-498-induced HMGA2 downregulation.

Authors:  Feng Qiu; Qiuchen Liu; Yanfu Xia; Hengxi Jin; Yuxin Lin; Xiaojun Zhao
Journal:  J Exp Clin Cancer Res       Date:  2022-01-14

Review 4.  The Crucial Roles of Bmi-1 in Cancer: Implications in Pathogenesis, Metastasis, Drug Resistance, and Targeted Therapies.

Authors:  Jie Xu; Lin Li; Pengfei Shi; Hongjuan Cui; Liqun Yang
Journal:  Int J Mol Sci       Date:  2022-07-26       Impact factor: 6.208

Review 5.  Vitamin D modulation and microRNAs in gastric cancer: prognostic and therapeutic role.

Authors:  Elena Gallardo Martin; Antia Cousillas Castiñeiras
Journal:  Transl Cancer Res       Date:  2021-06       Impact factor: 1.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.